UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
July 10, 2002
(Date of earliest event reported)
SANGSTAT MEDICAL CORPORATION
(Exact name of Registrant as specified in its charter)
|
Delaware |
|
0-22890 |
|
94-3076-069 |
|
(State of incorporation or organization) |
|
(Commission File No.) |
|
(IRS Employer Identification No.) |
|
|
|
|
|
|
|
|
|
6300 Dumbarton Circle Fremont, CA 94555 |
|
|
|
|
|
(Address of principal executive offices) |
|
|
|
|
|
|
|
|
|
|
|
(510) 789-4300 |
|
|
|
|
|
(Registrant’s telephone number, including area code) |
|
|
Item 5. Other Events.
The Board of Directors of SangStat Medical Corporation (the “Company”) appointed Corinne H. Lyle to its Board of Directors effective July 10, 2002. The Company issued a press release dated July 10, 2002 announcing Ms. Lyle’s appointment, a copy of which is filed herewith as Exhibit 99.1.
Item 7. Exhibits.
(a) Not applicable
(b) Not applicable
(c) Exhibits
|
Exhibit No. |
|
Description |
|
|
99.1 |
|
Press release dated July 10, 2002 |
|
2
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
SANGSTAT MEDICAL CORPORATION |
|
|
|
|
|
|
|
|
|
|
|
By: |
/s/ Stephen G. Dance |
|
|
|
Stephen G. Dance |
|
Date: July 15, 2002 |
|
Senior Vice President, Finance |
3
EXHIBIT INDEX
|
Exhibit No. |
|
Description |
|
|
99.1 |
|
Press release dated July 10, 2002 |
|
4